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G-proteins may be involved m receptor-mediated Ca’+-sensitization of smooth muscle contraction, but the responsible G-protems are not yet 
known. Here we show that m /I-escin skinned mesenteric microarteries. H-ras p?l proteins, predctivated with GTP or GTPyS, increase force at 
constant submaximal Ca’+ (pCa 6.3) concentration dependently. The GTP-bound form of the wild-type H-ras ~71 and the oncogenic mutant 
(p21[G12V]) were equally effective. The nucleotide-free and the inactive GDP-bound form of ras p21 had no effect on force. The tyrosine kinase 
inhibitor, tyrphostin, partially reversed the effect of the ras proteins m the GTP-bound form on force. Thus, ras proteins mimic the Ca”-sensitizing 
effect of GTPyS and vasoconstrictors in mesenteric microarteries which may mvolve tyrosme phosphorylation. 
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1. INTRODUCTION 
a-Adrenergic activation of vascular smooth muscle 
may occur with little if any change in membrane poten- 
tial ([l], pharmacomechanical coupling). Pharma- 
comechanical coupling involves at least two intracellu- 
lar signalling cascades leading to the IP, mediated re- 
lease of Ca2’ from intracellular stores [2] and sensitiza- 
tion of the myofilaments to Ca2’ [3,4]. The mechanism 
of the latter effect is not understood though it had been 
proposed that it may involve inhibition of myosin phos- 
phatase [5-71. a G protein coupled mechanism [4,8] pos- 
sibly involving rhoA ~21 [9] or activation of protein 
kinase C [lo]. Here we demonstrate, for the first time, 
a possible role of H-ras p21 in the mechanism causing 
Ca2’-sensitization of vascular smooth muscle. 
The effect of low molecular mass proteins, such as ras 
proteins, on tension development at ‘clamped’ [Ca”] 
can be investigated in smooth muscle preparations per- 
meabilized with p-escin. In these preparations, the re- 
ceptor effector coupling is still intact [l l] while at the 
same time the diffusion barrier for these proteins is 
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abolished. We tested two types of H-ras p21 (ras pro- 
teins), the wild-type H-ras p21 (c-ras) and its oncogenic 
mutant (~21 [G12V]; v-ras). Like the a-subunits of 
heterotrimeric G proteins, ras p21 can switch from an 
active GTP-bound form (GTP-ras) to an inactive GDP- 
bound form (GDP-ras) [12]. While the intrinsic GTPase 
activity of c-ras is stimulated by a GTPase activating 
protein (GAP), the GTPase activity of the oncogenic 
mutant, v-ras, is not subject to regulation by GAP [12]. 
The GTP-bound form of v-ras is therefore a perma- 
nently active form of ras p21. 
We have recently shown [13] that norepinephrine- 
induced contractions in intact mesenteric microarteries 
were inhibited by tyrosine kinase inhibitors. Here we 
show that the Ca”-sensitizing effect of the ras proteins 
is partially reversed by tyrphostin, a synthetic tyrosine 
kinase inhibitor [14], suggesting the involvement of pro- 
tein tyrosine phosphorylation in the ras p21 mediated 
increase in Ca’+-responsiveness. 
2. MATERIALS AND METHODS 
Female gumea pigs (ZOO-250 g body weight) were stunned and bled. 
Mesenteric microarteries (outer diameter in situ; 118 + 4 pm, II = 54) 
were isolated and mounted on a myograph as reported previously [15]. 
Followmg an equilibration period of about 60 mm m physiological salt 
solution buffered with HEPES (20 mM. pH 7.4 at 25°C) durmg which 
several contractions were elicited with KCI (125 mM), tissues were 
permeabihzed with 50 ,@ml /I-escin for 30 min at 25°C in relaxing 
solution. The relaxing solution contained (final concentration in mM): 
imidazole 20, EGTA 4, ATP 7.5. potassium methanesulfonate 110, 
magnesium acetate 10, NaN, 1, creatine phosphate IO, at pH 7.0 and 
25°C The contractmg solutions were obtained by varying the IXtlO 
of EGTA to Ca-EGTA [16]. To allow addition of proteins and guanos- 
ine nucleotides without diluting the ionic composition of the solutions, 
Publrshed by Elsewer Science Publrshers B V. 211 
Volume 324. number 2 FEBS LETTERS June 1993 
they were made up as doubly concentrated stock solutions and stored 
in ahquots at -20°C [16]. This concentrate was diluted twofold by the 
addition of (final concentrations) creatme kinase (100 U/ml). calmod- 
ulin (1 PM), leupeptin (1 PM). dithioerythritol (2 mM) as well as ras 
proteins and guanosine nucleotides when indicated. Solutions were 
contained in thermostatted 0.2- or l-ml cups. Prior to activation, each 
tissue was treated with 1 PM A23187 for 20 mm in the relaxing 
solution to deplete Ca” from the intracellular store sites. 
Recombinant nucleotide-free ras proteins were prepared as re- 
ported previously [17]. Protein concentration was determmed by the 
method of Bradford [18] using IgG as a standard To obtain the 
GTPyS-bound form of c-ras. 300,~~M nucleotide-free c-ras was reacted 
with 600pM GTPyS and I mM MgCl, (final volume IOO,LLI) for 5 min 
at 25°C. The excess GTPyS was removed by a commercial gel filtra- 
tion column (NAPS, Pharmacia) at 4°C in 20 mM imidazole [19]. In 
this way, 61 PM c-ras complexed with GTPyS was obtained. The 
protem was either shock frozen and stored at -80°C or kept on ice 
to minimize the dissociation of GTPyS and was used withm 6 h. To 
obtain the GTP- and GDP-bound form of ras protems. the nucleotide- 
free protein and the nucleotide were added to the mcubatton solution 
in the indicated concentrations and allowed to react for at least 5 min 
at 25°C prior to incubation of the tissues. The conditions were suffi- 
cient to exchange the nucleotides completely for the bound guanosine: 
the dissociation of the nucleotides and the cleavage of GTP is negligea- 
ble (cf. [17]). Tyrphostin was generously provided by J. Di Salvo, 
Dept. of Medical and Molecular Physiology. Umversity of Minnesota. 
Duluth, USA. 
Sfatrsncs Values are shown as means f S.E.M. ()z = number of ex- 
periments). Difference of responsiveness among groups was tested by 
the one-way analysis of variance, followed by paired or unpaired 
Student’s z-test. P values < 0.05 were considered as indicating signifi- 
cant differences. 
3. RESULTS 
Guinea pig mesenteric microarteries permeabilized 
with p-escin responded to activation with pCa 6.3 with 
a submaximal contraction which amounted to 24 & 4% 
of the maximal force obtained with pCa 4.9 (n = 24). 
GTPyS and Gpp(NH)p, two non-hydrolyzable GTP 
analogues, enhanced submaximal (Figs. 1A and 2D) but 
not maximal tension in this preparation. The effect of 
the GTP analogues was mimicked by c-ras preactivated 
with GTPyS (Fig. lB,C). As unbound GTPyS was re- 
moved by gel filtration, the increase in Ca’+-responsive- 
ness was unlikely due to activation of endogenous G 
proteins by free GTPyS. The possibility. however, re- 
mains that microarteries may contain GTP/GDP ex- 
change factors which might release GTPyS from 
GTPyS-ras. GTPyS may then bind to endogenous G 
proteins and permanently activate these. We addressed 
this problem by testing the effect of ras proteins acti- 
vated with GTP. 
Figs. 2 and 3 show that tension at submaximal Ca’+ 
was enhanced in the presence of 3 ,uM v-ras which was 
preactivated with different concentrations of GTP (0.01 
to 10 PM). Interestingly. c-ras preactivated with GTP 
was equally effective as v-ras in increasing Ca’+-respon- 
siveness (Fig. 3). Moreover, we did not observe a differ- 
ence in the time course (up to 12 min) of the tension 
response to the two GTP-ras proteins. In parallel exper- 
iments, we tested whether GTP when it is not bound to 
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ras proteins also affects submaximal force. Fig. 3 shows 
that GTP alone is less effective in increasing force at all 
concentrations tested. 
We performed several control experiments to test 
whether the effect of the GTP-ras proteins was specific 
for the active form. In the nucleotide free form, neither 
c- nor v-ras affected force (Fig. 2B). In the inactive, 
GDP-bound form, the ras proteins had only a minor 
effect on submaximal force (Fig. 2A). Thus, force in the 
presence of 3 PM v-ras bound to equimolar [GDP] was 
127 + 8% of the Cal+-activated force. In the presence of 
GDP-v-ras, the dose-response relation to GTP appears 
to be suppressed somewhat (Fig. 3), but this was not 
statistically significant. Following permanent activation 
of endogenous G proteins by Gpp(NH)p (0.3 PM) 
which increased Cal’-responsiveness 3- to 4-fold. nei- 
ther GTP nor GTP-ras proteins (Fig. 2D) produced a 
further increase in force. 
The ras p21 induced increase in Ca”-responsiveness 
was partially reversed by tyrphostin, a synthetic tyro- 
sine kinase inhibitor (Fig. 2B,C). Tyrphostin partially 
pCa 6 3 4.91 
B 
PCs 
C 
PCs - 8 6.3 
‘L9 I 
Fig. 1. Effect of c-ras preactivated with GTPyS on submaximal force 
in j-escm skinned mesenteric microarteries (A) Control, GTPyS (3 
PM) but not the ras-buffer increased force elicited by submaximal 
[Ca”]. (B and C) C-ras preactivated with GTPyS (see section 2) in- 
creased submaximal force concentration dependently. Threshold con- 
centration was < 0.6 PM. Following mcubation with high concentra- 
tions of preactivated c-ras, GTPyS had no further effect on force (C). 
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Fig. 2. Effect of ras proteins on submaxtmal force (elicrted at pCa 6.3) 
in mesenteric microarteries. (A) The inactive GDP bound form of ras 
(3 PM v-ras bound to eqmmolar GDP) has only a minor contractile 
effect. (B) Followmg activation with pCa 6.3, the mtcroartery was first 
incubated with nucleotide free ras and then with ras preactivated with 
GTP. Note that nucleottde free ras proteins (3 PM) were mixed with 
the indicated concentrattons of GTP at least 5 min prior to incubation 
of the tissue; rapid (spike hke) vertical tension changes indicate the 
solution changes to a new solution with the next higher [GTP] at 
constant [ras]. (C) Effect of GTP alone. (D) Gpp(NH)p enhanced 
submaximal force irreversibly (w.o. = washout), c-ras preactivated 
with GTP (cf. lane B) had no further effect on force, but force could 
be further enhanced by pCa 4.9. The tyrosine kinase inhibitor, tyr- 
phostin (50 PM), partially reversed the effects of GTP-ras and GTP 
(B-C). 
relaxed both the force enhanced by 3 PM v-ras preacti- 
vated with 10 FM GTP (GTP-ras: 250 ? 4% of Ca”- 
induced force, + tyrphostin: 150 ? 9%, n = 5) as well as 
the force enhanced by 10 PM GTP alone (GTP: 
140 + 13% of Ca”-induced force, + tyrphostin: 
124 + 12%, n = 4). Tyrphostin also partially reversed 
the tension increase induced by GTP bound c-ras but 
had no effect on Ca”-induced force [13]. 
ras) or only a minor effect (GDP-ras) on force. Follow- 
ing activation of endogenous G proteins with the non- 
hydrolyzable GTP analogue, Gpp(NH)p, exogenously 
added GTP-ras proteins no longer enhanced force sug- 
gesting that it may affect endogenous signalling path- 
ways involved in Ca”-sensitization (cf. Fig. 2D). It 
should be noted that the recombinant ras proteins used 
in this study are not post-translationally modified sug- 
gesting that their Ca”-sensitizing action does not re- 
quire post-translational modification. 
The Ca”-sensitizing effect was concentration-de- 
pendent and occurred at submicromolar concentrations 
of active ras proteins (0.6 PM GTPyS-ras or 3 PM ras 
proteins activated with 0.1 PM GTP). Although the 
GTP-ras complexes were not purified by gel filtration, 
the free [GTP] in the incubation solution was neglige- 
able when the ras proteins were activated with substoi- 
chiometric amounts of GTP due to the high affinity of 
ras proteins for GTP [17,20]. Furthermore, no signifi- 
cant dissociation of the nucleotides from the complexes 
has to be expected under our incubation conditions 
based on the work of Neal et al. [19] and the dissociation 
rate constants [17,20]. There is, however, some uncer- 
tainty concerning the stability of the GTP-ras complex 
within the microarteries as GTP may be released from 
the ras proteins by exchange factors and may then bind 
30: 
4. DISCUSSION 
In this study we present evidence that active H-ras 
p21 proteins increased force at constant submaximal 
[Ca2’] in p-escin skinned mesenteric microarteries. 
Thus, ras proteins in the GTP and GTPyS bound form 
mimicked the Ca2’-sensitizing effect of agonists such as 
norepinephrine [3,4] and non-hydrolyzable GTP ana- 
logues in vascular smooth muscle [3,4.6,8] while the 
inactive forms of ras proteins had no (nucleotide free 
total GTP(pM) 
Fig. 3. Summary of the effect of ras protems preactivated with GTP 
(a,.) in the concentrations given on the abscissa on submaximal force 
(pCa 6.3) Note that c-ras (0) and v-ras (m) were equally effective. GTP 
either alone (a) or in the continued presence of 3 PM GDP-v-ras (0) 
had a sigmficantly (asterix) smaller effect on force. Expertmental pro- 
tocol as in Ftg. 2B and C. Force was expressed relative to the tension 
ehctted by pCa 6.3 (control). Total GTP (given on the abscissa) mdi- 
cates either free [GTP] (experiments with GTP alone or in the presence 
of GDP-ras) or the concentrations of GTP (bound and free) with 
which the ras proteins were preactivated before incubatton of the 
tissues. Values are mean & S.E.M. of4 (0) and 8 microarteries (n.m.0). 
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to and activate endogenous G proteins; obviously the 
maximal concentration of released GTP would be equal 
to the concentration with which the ras proteins were 
activated. If this were the case, then GTP alone should 
increase force to a similar extent as GTP-ras. However, 
the effect of GTP alone was significantly smaller than 
that of GTP-ras (Fig. 3). 
In signalling cascades involving ras p2 1, phosphoryl- 
ation of proteins on tyrosyl residues (e.g. GAP and 
extracellular signal regulated kinase. MAP2 kinase) has 
been reported [2 1_23]. Tyrosine phosphorylation may 
also be involved in the increase in Ca”-responsiveness 
observed in the presence of GTP-ras as it is partially 
inhibited by the tyrosine kinase inhibitor, tyrphostin. As 
the cellular and mutant GTP-bound form of ras pro- 
teins were equally effective in increasing submaximal 
force GAP does not appear to be functional under our 
experimental conditions. This suggests that the CaZi- 
sensitization may involve tyrosine phosphorylation 
downstream of ras p2 1. e.g. MAP2 kinase. It is interest- 
ing to note that norepinephrine induced contractions in 
mesenteric microarteries are also inhibited by tyr- 
phostin [13] and in smooth muscle cells, several proteins 
are phosphorylated on tyrosyl residues in response to 
a number of vasoconstrictors [23]. 
Recently, it was reported that rhoA ~21. another 
small G protein. increases Ca”-sensitivity in saponin 
skinned smooth muscle [9]. This protein shares 3040% 
amino-acid sequence homology with ras p21 [34]. How 
ras p21 and rhoA p2 1 increase Ca”-responsiveness is 
presently unknown. The so far identified downstream 
effects of ras p21 and rho ~31 are different [23.25,36]. 
It is therefore unlikely that they interact with the same 
effector associated with the myofilaments. Signalling 
pathways involving ras ~21 and rho ~21 may. however. 
be coupled [27] probably in a hierarchical manner as has 
recently been observed in Swiss 3T3 cells [38]. Alterna- 
tively, they may act independently but have a common 
biological effect in smooth muscle cells. namely increas- 
ing Ca’+-sensitivity. 
In other cell systems, ras increases the arachidonic 
acid production [25] and activates MAP2 kinase [22]. 
Both effects, if operating in smooth muscle, may in- 
crease Ca”-sensitivity. Arachidonic acid increases 
Ca”-sensitivity of smooth muscle contraction. which is 
associated with an increase in myosin light chain phos- 
phorylation and inhibition of phosphatase [7]. MAP2 
kinase phosphorylates caldesmon [29,30], which results 
in weakening of the binding of caldesmon to actin [29]. 
Assuming that unphosphorylated caldesmon inhibits 
smooth muscle contraction [3 1.321, phosphorylation of 
caldesmon may be a mechanism to increase Ca’+-sensi- 
tivity independent of an increase in myosin light chain 
phosphorylation [33]. It will, therefore, be interesting to 
see whether active H-ras p2 1 increases arachidonic acid 
production and/or stimulates MAP2 kinase activity in 
smooth muscle cells. 
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